One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Diabetes Treatment Devices Market
Diabetes Treatment Devices Market
Diabetes Treatment Devices Market
Published date: Oct 2023 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Diabetes Treatment Devices Market

Global Diabetes Treatment Devices Market By Device Type BGM Devices, Continuous Glucose Monitoring Devices, Insulin Delivery Devices, By End User (Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, and Others), By Distribution Channel, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2032

  • Published date: Oct 2023
  • Report ID: 95307
  • Number of Pages: 390
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Device Type Analysis
    • Distribution Channel Analysis
    • End-User Analysis
    • Key Market Segments
    • Driver
    • Trend
    • Restraint
    • Opportunity
    • Regional Analysis
    • Key Players Analysis
    • Recent Development
    • Report Scope

    Report Overview

    Global Diabetes Treatment Devices Market size is expected to be worth around USD 17,599 Million by 2032 from USD 10,311 Million in 2023, growing at a CAGR of 6.3% during the forecast period from 2024 to 2032.

    Diabetes refers to a condition in which blood glucose levels rise beyond normal. This is due to a defect of insulin production. Blood glucose is the main source of energy. It can be obtained from the foods that we eat. The blood glucose levels are controlled by insulin, a pancreatic hormone. A defect in insulin synthesis can lead to diabetes. Normal blood glucose levels are between 70 and 100 mg/dL. Diabetes patients may experience an increase of 80-130 mg/dL. Diabetes care devices can be used to monitor the glucose levels of diabetic patients.

    A Continuous Glucose Monitor (CGM) is a medical device that continuously monitors the glucose levels of diabetic patients. This wearable technology is especially helpful for people with diabetes as it allows them to control their glucose levels. Many devices can monitor diabetes conditions. These include blood glucose monitor, ketone monitors, and continuous glucose monitors. These devices include smart insulin pens and continuous glucose monitors. To monitor and control glucose levels, glucose monitoring devices can be used. This helps to improve the patient’s overall health.

    Diabetes Treatment Devices Market Value

    Key Takeaways

    • Market Growth: Diabetes Treatment Devices Market size is expected to be worth around USD 17,599 Million by 2032 from USD 10,311 Million in 2023.
    • Market Share: The market growing at a CAGR of 6.3% during the forecast period from 2024 to 2032.
    • Device Types: Segmented into BGM, Continuous Glucose Monitoring, and Insulin Delivery Devices, offering diverse options.
    • Distribution Channels: Include hospital pharmacies, retail pharmacies, online pharmacies, and more, adapting to consumer preferences.
    • End-User Dominance: Hospitals held 40.9% of the market in 2021, while homecare is set to grow at a 7.4% CAGR.
    • Drivers: Obesity rates contribute to market growth, along with government initiatives, technological innovations, and awareness campaigns.
    • Regional Insights: North America dominates, benefiting from established healthcare infrastructure. The Asia-Pacific region is the fastest-growing due to increasing cancer cases.
    • Challenges: Painful sensor insertions and device usability challenges impact market expansion.
    • Opportunities: Increased funding, government initiatives, and supportive campaigns are anticipated to boost demand in the market.
    • Competitive Advantage: Novo Nordisk’s potential dominance in the diabetic treatment devices market.
    • Future Trends: The market’s trajectory is shaped by technology advancements, government awareness efforts, and diabetes prevention initiatives.

    Device Type Analysis

    Based on Device Type, the market for diabetes treatment devices is segmented into BGM Devices (Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets), Continuous Glucose Monitoring Devices (Sensors, Transmitters, Receiver), Insulin Delivery Devices (Pumps, Disposable pens, Cartridges in Reusable Pens, Syringes, Needles, Diagnostic, Others). The increase in diabetes awareness programs by governments and other organizations is expected to lead to more people using insulin devices.

    Distribution Channel Analysis

    Online pharmacies can purchase diabetes devices directly from manufacturers. This allows them to offer customers lucrative deals. This segment is driven by a growing awareness of online pharmacies among patients and an increase in public-private funding.

    Hospital pharmacies were responsible for high market penetration in recent years. This is due to their high footfall and the availability of products. Inpatient pharmacies and outpatient pharmacies are the two types of pharmacies that can be found within a hospital campus. The hospital’s inpatient pharmacy can only be accessed by authorized personnel.

    It is located within the hospital and serves operation rooms, ICUs, special service areas, and other areas. Outpatient pharmacies, on the other hand, are usually located in the hospital’s lobbies or entrances. The outpatient pharmacy has insulin delivery devices and handheld glucose meters. The COVID-19 pandemic had a positive impact on the e-pharmacies industry. Diabetes device sales volumes have increased via this platform.

    End-User Analysis

    This market was dominated by the hospital segment, which held 40.9% of the total market in 2021.

    The demand for this segment is increasing due to the rising number of diabetes patients admitted to hospitals. Three times as likely to be admitted for diabetes than those without it are patients with diabetes. In the last few years, diabetes technology has advanced rapidly. These technologies are designed to improve diabetes care in clinics and hospitals. These technological advances have led to an increase in insulin pump usage in clinics and hospitals. The homecare sector is expected to grow at a 7.4% Compound Annual Growth Rate (CAGR) over the forecast period. This is due to growing awareness of diabetes preventive care.

    The demand for insulin pumps in homecare settings is increasing due to increased awareness of diabetes by the government and an easy-to-use interface for insulin pumps. The demand for home care is also increasing due to the aging population. According to the World Health Organization, 80% of all the world’s elderly live in low- or middle-income countries. The total population of 60-year-olds and over is expected to grow to 2 billion by 2050. The demand for insulin pumps in home care settings is increasing because of the above-mentioned factors. This will lead to an exponential growth rate

    Diabetes Treatment Devices Market

    Key Market Segments

    Based on the Device Type

    • BGM Devices
    • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
    • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
    • Insulin Delivery Devices
    • Pumps
    • Disposable pens
    • Cartridges in Reusable Pens
    • Syringes
    • Needles
    • Diagnostic
    • Others

    Based on Distribution Channel

    • Hospital pharmacies
    • Retail Pharmacies
    • Diabetes Clinics/Centers
    • Institutional Sales
    • Online Pharmacies
    • Others

    Based on End-User

    • Hospitals
    • Homecare
    • Diagnostic Centers
    • Ambulatory Surgery Centers
    • Others

    Driver

    Increasing Prevalence of Diabetes Worldwide

    The primary driver of the diabetes treatment devices market is the global rise in diabetes prevalence, fueled by aging populations, sedentary lifestyles, and increasing obesity rates. The International Diabetes Federation estimates that over 537 million adults live with diabetes, projected to rise to 643 million by 2030.

    This escalating incidence necessitates advanced treatment devices such as insulin pumps, glucose monitors, and continuous glucose monitoring systems, driving significant market growth and innovation in treatment technologies to manage and monitor diabetes effectively.

    Trend

    Technological Advancements in Diabetes Devices

    A major trend shaping the diabetes treatment devices market is the rapid technological evolution in device functionalities and integration capabilities. Devices are becoming more user-friendly and precise, with features like real-time data tracking, long-term glucose monitoring, and seamless integration with smartphones and digital health platforms.

    This shift towards connected and smart devices enhances patient engagement and compliance, promoting better diabetes management. Innovations like artificial pancreas systems and minimally invasive sensor technologies further exemplify how technology is transforming diabetes care, making it more proactive and personalized.

    Restraint

    High Cost of Advanced Diabetes Treatment Devices

    One significant restraint in the diabetes treatment devices market is the high cost associated with advanced technologies. Devices such as insulin pumps and continuous glucose monitors (CGMs) are often expensive, making them less accessible to low-income patients and those without adequate insurance coverage.

    The cost barrier limits the adoption rate of these advanced devices, especially in developing regions where healthcare spending is constrained. Additionally, the need for regular maintenance and the recurrent cost of consumables, like sensors and test strips, add to the overall financial burden on patients.

    Opportunity

    Emerging Markets and Diabetes Management Programs

    Emerging markets present a considerable opportunity for expansion in the diabetes treatment devices sector due to increasing healthcare investments and a growing middle class. Countries like China, India, and Brazil are experiencing a surge in diabetes prevalence coupled with improved healthcare infrastructure and increased healthcare spending.

    Moreover, government initiatives and diabetes management programs aiming to enhance disease awareness and promote advanced treatment modalities open new avenues for market penetration. These factors collectively offer device manufacturers a lucrative potential to expand their global footprint and innovate solutions tailored to regional needs.

    Regional Analysis

    North America is the dominant market for diabetes treatment devices due to its well-developed healthcare infrastructure, favorable reimbursement policies, and strong regional leadership.

    The Asia-Pacific region is projected to experience the fastest growth in the period 2024-2032. This is due to increasing cancer incidences in the patients such as bladder, liver, bladder, and esophageal, as well as the increased presence of major U.S. manufacturers, technological advances, and increasing foreign investment. This will affect the market’s recent and future trends.

    Diabetes Treatment Devices Market Region

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    Diabetes treatment devices market is expected to grow during the forecast period due to an increasing prevalence of diabetes. According to the International Diabetes Federation Report 2017, 66.0 million people worldwide have diabetes. This number is expected to rise to 81.0 million by 2045, according to the report. The United Kingdom, France, and Germany are the top five countries with diabetes in Global. It has been shown that North America has more than 29 million diabetes patients. This number is expected to rise to 34 million in 2027. In 2021, the United States alone had more than 26,000,000 diabetes patients. This increases market growth.

    Market Key Players

    • Medtronic plc
    • Abbott Laboratories
    • Hoffmann-La-Ltd.
    • Bayer AG
    • Lifescan, Inc.
    • B Braun Melsungen AG
    • Lifescan, Inc.
    • Dexcom Inc.
    • Insulet Corporation
    • Ypsomed Holdings
    • Other key players.

    Recent Development

    • Simplera CGM (August 2024): Medtronic received FDA approval for Simplera CGM, a new continuous glucose monitor that is half the size of previous models. This device simplifies the diabetes management process and is part of Medtronic’s strategy to integrate with their InPen smart insulin pen app to create a comprehensive diabetes management system​.
    • Abbott (August 2024): Medtronic also announced a global partnership with Abbott to integrate Abbott’s advanced CGM platform with Medtronic’s smart dosing devices and software. This collaboration is set to enhance Medtronic’s diabetes care solutions, providing more options and advanced care to people with diabetes​.
    • EOFlow Co. Ltd. (July 2023): Medtronic plc expanded its diabetes offerings by acquiring EOFlow Co. Ltd., a South Korean company specializing in the EOPatch, a tubeless, wearable, and fully disposable insulin delivery device.

    Report Scope

    Report Features Description
    Market Value (2023) USD 10,311 Mn
    Forecast Revenue (2032) USD 17,599 Mn
    CAGR (2024-2032) 6.3%
    Base Year for Estimation 2023
    Historic Period 2016-2022
    Forecast Period 2024-2032
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered Based on the Device Type- BGM Devices (Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, and Lancets), Continuous Glucose Monitoring Devices,( Sensors, Transmitters, and Receiver), Insulin Delivery Devices, (Pumps, Disposable pens, Cartridges in Reusable Pens, Syringes, Needles, Diagnostic, and Others);  Based on Distribution Channel- Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Institutional Sales, Online Pharmacies, and Others, and Based on End-User- Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, and sOthers.
    Regional Analysis North America – The US, Canada, Mexico; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Eastern Europe – Russia, Poland, The Czech Republic, Greece Rest of Eastern Europe; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA.
    Competitive Landscape Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Other key players.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
    Diabetes Treatment Devices Market
    Diabetes Treatment Devices Market
    Published date: Oct 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Medtronic plc
    • Abbott Laboratories
    • Hoffmann-La-Ltd.
    • Bayer AG Company Profile
    • Lifescan, Inc.
    • B Braun Melsungen AG
    • Dexcom Inc.
    • Insulet Corporation
    • Ypsomed Holdings
    • Other key players.
  • settingsSettings

Related Reports

  • Diabetes Wearables Market
  • Diabetes Devices Market
  • Bandage Contact Lenses Market
  • Refurbished Dental Equipment & Maintenance Market
  • Double-coated Medical Tapes Market
  • Interventional Oncology Ablation Market
  • Prosthetic Disc Nucleus Market
  • Knee Hyaluronic Acid Injections Market
  • Operating Room/OR Integration Market
  • Full Body Scanner Market

Our Clients

  • Our Clients
Inquiry Before Buying

Diabetes Treatment Devices Market
  • 95307
  • Oct 2023
    • ★★★★★
      ★★★★★
    • (24)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.